INOVA
C

Preconception Diabetes Care in the United States: Policy and Equity

By INOVA FEATURING Chloe Zera
By INOVA FEATURING Chloe Zera
65 views
January 5, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Related Content

AUTOPLAY
47:11
Houston Methodist

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
23:35
Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

08:35
Susan Brian

Labs to Check on Semaglutide or Tirzepatide

20:15
Omnipod®

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Feat. F. Pasquel
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

40:48
Michigan Medicine

Incretin-based Therapies in the Management of Obesity and its Comorb…

Feat. A. Rothberg
26:49
Diana Isaacs

Tirzepatide Updates

07:41
Susan Brian

Weightloss in Menopause

33:23
Keck School of Medicine of USC

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Feat. M. Goran
26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
12:40
Robert Busch

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

03:16
Michigan Medicine - Podiatry

Diabetic Peripheral Neuropathy: A Review of Clinical Practice Guidel…

Feat. G. Rothenberg
05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

11:07
Susan Brian

Wegovy 2024 Updates